LifeStance director sells 500,000 shares

LifeStance Health Group, Inc. director Kenneth A. Burdick reported a sale of 500,000 shares of common stock on 2026-08-11 at a weighted average price of $11.51 per share, with individual trades between $11.50 and $11.665.

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Kenneth A. Burdick reported a sale of 500,000 shares of common stock on 2026-08-11 at a weighted average price of $11.51 per share, with individual trades between $11.50 and $11.665. Following this sale, he directly holds 2,970,810 shares and indirectly holds 46,511 shares through Burdick Family LLC.

Insider Trade Summary

Net Seller: 500,000 shares

Net Sell 2 txns

Insider Burdick Kenneth A

Role Director

Sold 500,000 shs ($5.75M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	500,000	$11.51	$5.75M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,970,810 shares (Direct); Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)

Footnotes (1)

1. F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $11.50 to $11.665 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Key Figures

Shares sold: 500,000 shares Weighted average sale price: $11.51 per share Sale price range: $11.50 to $11.665 per share +3 more

6 metrics

Shares sold 500,000 shares Common stock sale reported on 2026-08-11

Weighted average sale price $11.51 per share Price for 500,000 shares sold on 2026-08-11

Sale price range $11.50 to $11.665 per share Range of prices across multiple sale transactions

Direct holdings after sale 2,970,810 shares Common stock directly owned following the transaction

Indirect holdings 46,511 shares Common stock held indirectly by Burdick Family LLC

Net shares sold 500,000 shares Net change in reported buy/sell activity in this Form 4

Key Terms

weighted average price, indirect, open market or private transaction

3 terms

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

indirect financial

"Common Stock holdings reported as indirect, By Burdick Family LLC"

open market or private transaction financial

"Transaction code S indicates a Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LFST director Kenneth Burdick report?

Kenneth A. Burdick reported selling 500,000 shares of LifeStance Health Group common stock on 2026-08-11 at a weighted average price of $11.51 per share, with trades occurring between $11.50 and $11.665.

At what price were the LFST shares sold by Kenneth Burdick?

The reported sale used a weighted average price of $11.51 per LFST share. According to the footnote, the multiple transactions occurred in a price range from $11.50 to $11.665 per share on 2026-08-11.

How many LFST shares does Kenneth Burdick hold after the reported sale?

After the reported sale, Kenneth A. Burdick directly holds 2,970,810 LFST shares. In addition, an indirect holding entry shows 46,511 shares held by Burdick Family LLC, reflecting his associated indirect ownership.

Is any of Kenneth Burdick’s LFST ownership held indirectly?

Yes. The Form 4 lists an indirect position of 46,511 LFST shares held “By Burdick Family LLC”. This is separate from his 2,970,810 shares of direct ownership reported following the sale transaction.

How many LFST shares in total did Kenneth Burdick sell in this Form 4?

The filing reports that Kenneth A. Burdick sold 500,000 shares of LifeStance Health Group common stock. The footnote explains these were executed as multiple transactions within a price range of $11.50 to $11.665 per share.

Was the LFST insider sale price a single trade price or an average?

The reported price of $11.51 per share is a weighted average price. The footnote states that the 500,000 shares were sold in multiple transactions at prices between $11.50 and $11.665, with full breakdowns available on request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 05:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burdick Kenneth A

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		S		500,000(1)	D	$11.51	2,970,810	D
Common Stock								46,511	I	By Burdick Family LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $11.50 to $11.665 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

	By: /s/ Ryan Pardo, Attorney-in-Fact	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)